Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer

NCT03054363 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Tucatinib in Combination with Palbociclib and Letrozole
DRUG: Tucatinib in Combination with Palbociclib and Letrozole

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]
[object Object]